Pharmamarketeer

FDA authorizes first machine learning-based COVID-19 non-diagnostic screening device

Machine learning

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first machine learning-based Coronavirus Disease 2019 (COVID-19) non-diagnostic screening device that identifies certain biomarkers that are indicative of some types of conditions, such as hypercoagulation (a condition causing blood to clot more easily than normal).

Advertentie(s)